PMID: 11100963

Choo-Kang LR, Zeitlin PL
Type I, II, III, IV, and V cystic fibrosis transmembrane conductance regulator defects and opportunities for therapy.
Curr Opin Pulm Med. 2000 Nov;6(6):521-9., [PubMed]
Sentences
No. Mutations Sentence Comment
22 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 11100963:22:30
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 11100963:22:38
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 11100963:22:23
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 11100963:22:70
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Gln39*
X
ABCC7 p.Gln39* 11100963:22:45
status: NEW
view ABCC7 p.Gln39* details
ABCC7 p.Arg75*
X
ABCC7 p.Arg75* 11100963:22:57
status: NEW
view ABCC7 p.Arg75* details
ABCC7 p.Ser1196*
X
ABCC7 p.Ser1196* 11100963:22:82
status: NEW
view ABCC7 p.Ser1196* details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 11100963:22:51
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Leu719*
X
ABCC7 p.Leu719* 11100963:22:63
status: NEW
view ABCC7 p.Leu719* details
The nonsense mutations G542X, W1282X, R553X, Q39X, E60X, R75X, L719X, Y1092X, and S1196X significantly reduce the levels of mutant CFTR mRNA to 5 to 30% of wild-type levels [28]. Login to comment
31 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 11100963:31:43
status: NEW
view ABCC7 p.Trp1282* details
Interestingly, one patient who carried the W1282X/3849 + 10kbC→T genotype showed complete normalization of chloride transport on NPD following gentamicin administration [31••]. Login to comment
37 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:37:490
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:37:491
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:37:603
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:37:604
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11100963:37:732
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11100963:37:733
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 11100963:37:345
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 11100963:37:346
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 11100963:37:163
status: NEW
view ABCC7 p.Gly542* details
Molecular fate of CFTR protein Type of genetic defect and example Class-specific potential therapeutic approach Specific clinical examples I No synthesis Nonsense G542X Frameshift 394delTT Splice junction 1717-1G→A Aminoglycoside readthrough of premature termination site Gentamicin II Trafficking block AA deletion ∆F508 Missense N1303K Manipulation of intracellular folding environment (chemical or molecular chaperones) Phenylbutyrate, CPX III Block in regulation Missense G551D Stimulation of membrane localized mutant channel Genistein, MPB- compounds IV Altered conductance Missense R117H Augmentation of mutant channel conductance Milrinone, adenosine nucleotides V Reduced synthesis of normal protein Missense A455E Alternative splicing 3849+10kbC→T Maximal activation of decreased but functionally normal channels Stimulation of mRNA and protein synthesis ? Login to comment
52 ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 11100963:52:76
status: NEW
view ABCC7 p.Gly480Cys details
Since "misfolding" of the ∆F508 CFTR and other class II mutants (eg, G480C) does not completely abolish CFTR chloride conductance [44-46], therapies can be aimed primarily at overcoming the trafficking block, thereby permitting surface expression of the partially active mutant channel. Login to comment
89 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:89:0
status: NEW
view ABCC7 p.Gly551Asp details
G551D is localized at the cell surface but exhibits impaired ATP binding and does not conduct chloride in response to elevated cAMP [71,72]. Login to comment
90 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:90:0
status: NEW
view ABCC7 p.Gly551Asp details
G551D is typically associated with pancreatic insufficiency and a severe phenotype. Login to comment
92 ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11100963:92:33
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 11100963:92:40
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 11100963:92:52
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 11100963:92:25
status: NEW
view ABCC7 p.Ser1255Pro details
These mutants, including S1255P, G551S, G1244E, and G1349D, sustain a reduced response to ATP. Login to comment
97 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:97:59
status: NEW
view ABCC7 p.Gly551Asp details
In a small study of five CF patients carrying at least one G551D mutation, perfusion of the nasal mucosa with genistein stimulated chloride-dependent NPD to an average of 16.9% of the responses found in healthy subjects [77••]. Login to comment
106 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:106:29
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 11100963:106:43
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 11100963:106:54
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Gly314Glu
X
ABCC7 p.Gly314Glu 11100963:106:36
status: NEW
view ABCC7 p.Gly314Glu details
These CFTR mutants including R117H, G314E, R334W, and R347P demonstrate a reduction in their chloride conductance or abnormal channel gating (see Fig. 2). Login to comment
108 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:108:49
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 11100963:108:59
status: NEW
view ABCC7 p.Pro574His details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 11100963:108:0
status: NEW
view ABCC7 p.Arg347Pro details
R347P affects the rate of chloride flow, whereas R117H and P574H reduce the channel open time. Login to comment
113 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:113:127
status: NEW
view ABCC7 p.Gly551Asp details
Although a recent study failed to demonstrate a significant effect of milrinone on chloride secretion in both ∆F508 and G551D CF patients [83], phosphodiesterase inhibitors such as rolipram, papaverine, and IBMX (3-isobutyl-1- methyxanthine) may still be beneficial for less stringent mutations. Login to comment
114 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:114:12
status: NEW
view ABCC7 p.Arg117His details
In a murine R117H model, milrinone in combination with foskolin resulted in a favorable NPD measurement change [84]. Login to comment
116 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11100963:116:133
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11100963:116:140
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 11100963:116:151
status: NEW
view ABCC7 p.Gly1349Asp details
Through this mechanism, adenosine indirectly activates wild-type as well as several surface-localized mutant CFTR channels including R117H, A455E, and G1349D. Login to comment
117 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11100963:117:65
status: NEW
view ABCC7 p.Gly551Asp details
Adenosine combined with rolipram or papaverine can also activate G551D CFTR measured by halide efflux to approximately 30% of wild-type activity [86]. Login to comment
124 ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 11100963:124:53
status: NEW
view ABCC7 p.Pro574His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11100963:124:63
status: NEW
view ABCC7 p.Ala455Glu details
Missense mutations that belong to this class include P574H and A455E. Login to comment